Boehringer Ingelheim and BioMed X have successfully applied a crowdsourcing approach to establish a global research team of scientists for COPD research.
The FDA says it is focusing on multicultural youth in the hip-hop peer crowd because they are more likely to use tobacco than other youth.
Satisfaction with an inhaler was only one of several factors that predicted a positive outcome in asthma patients.
Ex-smokers initially faced an even higher risk of diabetes, but as more years pass without cigarette use their odds of getting the disease gradually diminished.
An analysis of genetic data revealed new associations between lung function and smoking behavior.
Fifteen New York City water-cooling towers were found to be contaminated with Legionnaires’ disease after being disinfected less than two months ago.
The reason why many doctors find electronic health records (EHR) difficult to use might be that the software wasn't properly tested, researchers suggest.
The National Institute of Health’s National Cancer Institute (NCI) has awarded a grant to a multidisciplinary team of disease and research experts developing a mathematical model to predict and demonstrate autophagy in lung cancer.
RespirTech is now offering new vest patterns and custom decorative decals for its inCourage Airway Clearance System, used to treat cystic fibrosis, COPD, and bronchiectasis.
Smart inhalers are part of a new wave of digital technology designed to improve the management of lung diseases.
A study of more than 12,000 Finnish babies found that those who were given inhaled corticosteroids during the first 2 years of life were too short for their age.
The FDA has approved the use of ambrisentan (Letairis) in combination with tadalafil (Cialis) as up-front therapy for pulmonary arterial hypertension (PAH) to reduce the risk of worsening disease and improve exercise ability.
Focus Diagnostics’ influenza and RSV molecular test has been cleared for an additional 46 influenza A and influenza B strains and seven additional RSV strains.
Researchers at Harvard University have found that smokers with COPD may face nearly twice the risk of getting small cell lung cancer (SCLC) than those without the disease.
A large study suggests breathing in tiny particles of toxic chemicals from the air could lead to an increased risk of premature death, according to HealthDay.
Respiratory caregivers in the US military have both the challenge and the privilege of serving their country and their patients, both at home and abroad, in peace and in combat.
Boehringer Ingelheim announces that the results of OTEMTO 1 & 2 reinforce the benefits of Spiolto Respimat as first line maintenance therapy for COPD.
According to Novavax, study data show that immunizing pregnant women with its RSV vaccine is safe and can protect infants against the virus.
Aradigm has announced the completion of patient enrollment for ORBIT-4, a clinical trial of Pulmaquin for non-cystic fibrosis bronchiectasis.
There is insufficient awareness of the health risks caused by the inhalation of talc, and this lack of awareness needs to be addressed urgently, according to research presented at ERS 2015.